Cargando…

SUN-313 Insulinoma: Secreting but Not Appearing

Introduction: The diagnosis of an insulinoma requires clinical suspicion and confirmatory biochemical testing. Insulinomas are localized using computed tomography (CT), magnetic resonance imaging (MRI), endoscopic ultrasonography and if needed selective pancreatic arterial calcium injections with me...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Sapna, Dackiw, Alan, Moore, William, Abramowitz, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553422/
http://dx.doi.org/10.1210/js.2019-SUN-313
_version_ 1783424816600055808
author Patel, Sapna
Dackiw, Alan
Moore, William
Abramowitz, Jessica
author_facet Patel, Sapna
Dackiw, Alan
Moore, William
Abramowitz, Jessica
author_sort Patel, Sapna
collection PubMed
description Introduction: The diagnosis of an insulinoma requires clinical suspicion and confirmatory biochemical testing. Insulinomas are localized using computed tomography (CT), magnetic resonance imaging (MRI), endoscopic ultrasonography and if needed selective pancreatic arterial calcium injections with measurements of hepatic venous insulin levels (1). Clinical Case: A 71 year old female with no significant past medical history was referred for evaluation of hypoglycemia. She was noted to have frequent episodes of symptomatic fasting and post-prandial hypoglycemia for two years prior to presentation. Symptoms associated with hypoglycemia included: weakness, diaphoresis, and peri-oral numbness which resolved after treatment with high carbohydrate foods or juice. On several occasions severe hypoglycemia required emergency services assistance. Endocrine evaluation at an outside clinic during an episode of hypoglycemia found a serum glucose of 30 mg/dL, elevated insulin level (20 U/ml, n<3.0 U/mL), C-peptide (4.3 ng/mL, n<0.6 ng/mL), and proinsulin (130 pmol/L, n<5.0 pmol/L) levels. All other laboratory work was normal. CT scan of the abdomen localized a lesion to the tail of the pancreas, but based on radiographic appearance differential diagnosis included a splenule. She underwent an endoscopic ultrasound and magnetic resonance cholangiopancreatography of the abdomen both of which were unable to characterize the lesion. Given high clinical suspicion, an intra-arterial calcium stimulation test was conducted, with inconclusive results. A gallium-68 Dotatate scan showed Dotatate uptake, without further distinction. Given the challenge of identifying the lesion, the decision was made in collaboration with radiology to complete a Tectnetium-99m sulfur colloid single-photon emission computed tomography (SPECT)/CT scan. This imaging modality shows accumulation of sulfur colloid in normal splenic tissue and is expected to show no radiotracer uptake in pancreatic tissue (2). The scan showed no significant accumulation in the area of concern presenting high suspicion for a neuroendocrine tumor. Endocrine Surgery completed a partial pancreatectomy with removal of a 1.4 cm tumor. Pathology was consistent with insulinoma. Post-operatively the patient had complete resolution of her hypoglycemia. Conclusion: This case highlights a diagnostic challenge which required interdisciplinary collaboration to use alternative imaging to localize an insulinoma preoperatively. References: (1) Cryer, PE, Axelrod L, Grossman, AB, et al. Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinool Metab. 2009; 94;709-728. (2) Castellani, M, Cappellini, MD, Cappelletti, M, et al. Tc-99m Sulphur Colloid Scintigraphy in the Assessment of Splenic Tissue after Splenectomy. Clinical Radiology. 2001;56;596-98.
format Online
Article
Text
id pubmed-6553422
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65534222019-06-13 SUN-313 Insulinoma: Secreting but Not Appearing Patel, Sapna Dackiw, Alan Moore, William Abramowitz, Jessica J Endocr Soc Tumor Biology Introduction: The diagnosis of an insulinoma requires clinical suspicion and confirmatory biochemical testing. Insulinomas are localized using computed tomography (CT), magnetic resonance imaging (MRI), endoscopic ultrasonography and if needed selective pancreatic arterial calcium injections with measurements of hepatic venous insulin levels (1). Clinical Case: A 71 year old female with no significant past medical history was referred for evaluation of hypoglycemia. She was noted to have frequent episodes of symptomatic fasting and post-prandial hypoglycemia for two years prior to presentation. Symptoms associated with hypoglycemia included: weakness, diaphoresis, and peri-oral numbness which resolved after treatment with high carbohydrate foods or juice. On several occasions severe hypoglycemia required emergency services assistance. Endocrine evaluation at an outside clinic during an episode of hypoglycemia found a serum glucose of 30 mg/dL, elevated insulin level (20 U/ml, n<3.0 U/mL), C-peptide (4.3 ng/mL, n<0.6 ng/mL), and proinsulin (130 pmol/L, n<5.0 pmol/L) levels. All other laboratory work was normal. CT scan of the abdomen localized a lesion to the tail of the pancreas, but based on radiographic appearance differential diagnosis included a splenule. She underwent an endoscopic ultrasound and magnetic resonance cholangiopancreatography of the abdomen both of which were unable to characterize the lesion. Given high clinical suspicion, an intra-arterial calcium stimulation test was conducted, with inconclusive results. A gallium-68 Dotatate scan showed Dotatate uptake, without further distinction. Given the challenge of identifying the lesion, the decision was made in collaboration with radiology to complete a Tectnetium-99m sulfur colloid single-photon emission computed tomography (SPECT)/CT scan. This imaging modality shows accumulation of sulfur colloid in normal splenic tissue and is expected to show no radiotracer uptake in pancreatic tissue (2). The scan showed no significant accumulation in the area of concern presenting high suspicion for a neuroendocrine tumor. Endocrine Surgery completed a partial pancreatectomy with removal of a 1.4 cm tumor. Pathology was consistent with insulinoma. Post-operatively the patient had complete resolution of her hypoglycemia. Conclusion: This case highlights a diagnostic challenge which required interdisciplinary collaboration to use alternative imaging to localize an insulinoma preoperatively. References: (1) Cryer, PE, Axelrod L, Grossman, AB, et al. Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinool Metab. 2009; 94;709-728. (2) Castellani, M, Cappellini, MD, Cappelletti, M, et al. Tc-99m Sulphur Colloid Scintigraphy in the Assessment of Splenic Tissue after Splenectomy. Clinical Radiology. 2001;56;596-98. Endocrine Society 2019-04-30 /pmc/articles/PMC6553422/ http://dx.doi.org/10.1210/js.2019-SUN-313 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Tumor Biology
Patel, Sapna
Dackiw, Alan
Moore, William
Abramowitz, Jessica
SUN-313 Insulinoma: Secreting but Not Appearing
title SUN-313 Insulinoma: Secreting but Not Appearing
title_full SUN-313 Insulinoma: Secreting but Not Appearing
title_fullStr SUN-313 Insulinoma: Secreting but Not Appearing
title_full_unstemmed SUN-313 Insulinoma: Secreting but Not Appearing
title_short SUN-313 Insulinoma: Secreting but Not Appearing
title_sort sun-313 insulinoma: secreting but not appearing
topic Tumor Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553422/
http://dx.doi.org/10.1210/js.2019-SUN-313
work_keys_str_mv AT patelsapna sun313insulinomasecretingbutnotappearing
AT dackiwalan sun313insulinomasecretingbutnotappearing
AT moorewilliam sun313insulinomasecretingbutnotappearing
AT abramowitzjessica sun313insulinomasecretingbutnotappearing